Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9256222 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty
Condition: Angioplasty, Transluminal, Percutaneous Coronary
Intervention: Drug: abciximab bolus, abciximab bolus plus infusion, or placebo

Indicates status has not been verified in more than two years